Type 2 asthma endotype | | | |
Eosinophils | Bronchoscopy Bronchial biopsy BAL | | Invasive and not feasible in routine clinical practice Contraindicated in cases of severe airway obstruction No consensus on clear cut-off values
|
Induced sputum | Feasible in advanced clinical settings Sampling of central airway inflammation Cut-off of ≥3% to indicate sputum eosinophilia May indicate steroid responsiveness
| |
Peripheral blood | Easily obtained, even in younger children Correlation with sputum eosinophil counts (except during systemic corticosteroid treatment) Cut-off of ∼300 cells·μL−1 to indicate eosinophilic inflammation
| Daily variations in number Affected by secondary causes of eosinophilia (i.e. parasitosis, common in children) No demonstrated correlation with airway eosinophilia
|
IgE | Peripheral blood | | |
Periostin | Peripheral blood | | Baseline levels are higher in children, probably due to growth Conflicting results in children Not available in most laboratories
|
FENO | Exhaled breath | | |
VOCs | Exhaled breath | | |
pH, markers of oxidative stress, leukotrienes, cytokines and chemokines | Exhaled breath condensate | | |
Non-type 2 asthma endotype | | | |
Neutrophils | Bronchoscopy
Bronchial biopsy
BAL
| | Invasive and not feasible in routine clinical practice Contraindicated in cases of severe airway obstruction No consensus on clear cut-off values
|
Induced sputum | | |
Peripheral blood | | |